salicylic acid has been researched along with diflunisal in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (17.39) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 8 (34.78) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Hannah, J; Holtz, WJ; Houser, RA; Jones, H; Kelly, KW; Matzuk, AR; Ruyle, WV; Sarett, LH; Shen, TY; Witzel, BE | 1 |
| Fordice, MW; Greenwald, RB; Hannah, J; Jacobs, A; Jones, H; Ruyle, WV; Shen, TY; Walford, GL | 1 |
| Apiwattanakul, N; Chairoungdua, A; Endou, H; Kanai, Y; Nakajima, N; Sekine, T; Sophasan, S | 1 |
| Strassburg, CP; Tukey, RH | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Anacardio, R; Aureli, L; Cesta, MC; Cruciani, G; De Simone, L; Moriconi, A | 1 |
| Bayram, E; Kufrevioglu, OI; Senturk, M; Supuran, CT | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Buttar, D; Colclough, N; Gerhardt, S; MacFaul, PA; Maskos, K; Phillips, SD; Plowright, A; Steinbacher, S; Steuber, H; Tam, K; Whittamore, P | 1 |
| Hong, S; Jung, Y; Kang, S; Kim, J; Kim, YM; Yum, S | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Altman, RA; Borel, T; Davis, I; de Azambuja, F; Johnson, D; Liu, A; Sorrentino, JP; Udokwu, C; Yang, Y | 1 |
| Brantmark, B; Hedner, U; Melander, A; Wåhlin-Boll, E | 1 |
| Brantmark, B; Forshell, GP; Fredholm, B; Hedner, U; Melander, A; Nitelius, E; Wåhlin-Boll, E | 1 |
| Nordt, SP | 1 |
| Larsen, C; Larsen, SW; Parshad, H; Østergaard, J | 1 |
| Alañón Molina, A; Fernández López, P; Murillo Pulgarín, JA; Sánchez-Ferrer Robles, I | 1 |
| Aichelmann-Reidy, ME; Prudencio, A; Reynolds, MA; Uhrich, KE; Woodward, K | 1 |
| Alañón Molina, A; Murillo Pulgarín, JA; Sánchez-Ferrer Robles, I | 1 |
| Lee, IS; Lim, HW; Maksimoska, J; Man, N; Marmorstein, R; Meier, J; Newman, JC; Nimer, S; Ott, M; Schröder, S; Shimazu, T; Shirakawa, K; Sorum, AW; Verdin, E; Wang, L | 1 |
| Józefowicz, M; Kwela, J; Lewkowicz, A; Miotke-Wasilczyk, M | 1 |
1 review(s) available for salicylic acid and diflunisal
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
22 other study(ies) available for salicylic acid and diflunisal
| Article | Year |
|---|---|
Novel analgesic-antiinflammatory salicylates.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical Phenomena; Chemistry; Dogs; Rats; Salicylates; Structure-Activity Relationship | 1978 |
Synthesis and analgesic-antiinflammatory activity of some 4- and 5-substituted heteroarylsalicylic acids.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemical Phenomena; Chemistry, Physical; Dogs; Edema; Gastrointestinal Hemorrhage; Rats; Salicylates | 1978 |
Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in Xenopus laevis oocytes.
Topics: Animals; Anion Transport Proteins; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport; Carrier Proteins; Oocytes; Xenopus laevis | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Binding Sites; Chemical Phenomena; Chemistry, Physical; Humans; In Vitro Techniques; Interleukin-8; Models, Molecular; Phenylpropionates; Protein Binding; Quantitative Structure-Activity Relationship; Serum Albumin; Stereoisomerism | 2005 |
In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.
Topics: Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Cytosol; Humans; Inhibitory Concentration 50; Molecular Structure; Salicylic Acid; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions.
Topics: Binding Sites; Crystallography, X-Ray; Drug Interactions; Humans; Pharmaceutical Preparations; Protein Binding; Protein Structure, Tertiary; Serum Albumin; Spectrometry, Fluorescence | 2010 |
Structure-activity relationship of salicylic acid derivatives on inhibition of TNF-α dependent NFκB activity: Implication on anti-inflammatory effect of N-(5-chlorosalicyloyl)phenethylamine against experimental colitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Survival; Chemokine CXCL2; Colitis; HCT116 Cells; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Molecular Structure; NF-kappa B; Rats; Salicylates; Spectrophotometry, Infrared; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Diflunisal Derivatives as Modulators of ACMS Decarboxylase Targeting the Tryptophan-Kynurenine Pathway.
Topics: Bacterial Proteins; Binding Sites; Biosynthetic Pathways; Carboxy-Lyases; Catalytic Domain; Crystallography, X-Ray; Diflunisal; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kynurenine; Molecular Docking Simulation; NAD; Pseudomonas fluorescens; Structure-Activity Relationship; Tryptophan | 2021 |
Salicylate inhibition of antiplatelet effect of aspirin.
Topics: Aspirin; Diflunisal; Humans; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Salicylates; Salicylic Acid | 1981 |
Actions and interactions of acetylsalicylic acid, salicylic acid and diflunisal on platelet aggregation.
Topics: Adult; Aspirin; Diflunisal; Drug Interactions; Female; Humans; Male; Middle Aged; Platelet Aggregation; Salicylates; Salicylic Acid | 1984 |
Diflunisal cross-reactivity with the Trinder method for salicylate determination.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diflunisal; Enzyme Inhibitors; Humans; Male; Salicylates; Salicylic Acid | 1996 |
Bupivacaine salts of diflunisal and other aromatic hydroxycarboxylic acids: aqueous solubility and release characteristics from solutions and suspensions using a rotating dialysis cell model.
Topics: Bupivacaine; Chromatography, High Pressure Liquid; Dialysis; Diflunisal; Hydrogen-Ion Concentration; Hydroxybenzoates; Salicylic Acid; Solubility; Solutions; Suspensions | 2005 |
Direct determination of closely overlapping drug mixtures of diflunisal and salicylic acid in serum by means of derivative matrix isopotential synchronous fluorescence spectrometry.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diflunisal; Humans; Pharmaceutical Preparations; Salicylic Acid; Sensitivity and Specificity; Software; Spectrometry, Fluorescence | 2007 |
Non-steroidal anti-inflammatory drug (NSAID)-derived poly(anhydride-esters) in bone and periodontal regeneration.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Bone and Bones; Bone Demineralization Technique; Bone Regeneration; Diflunisal; Esters; Humans; Hydrolysis; Inflammation; Lactic Acid; Periodontium; Polyanhydrides; Polyesters; Polymers; Random Allocation; Rats; Rats, Wistar; Regeneration; Salicylic Acid; Wound Healing | 2007 |
Rapid simultaneous determination of four non-steroidal anti-inflammatory drugs by means of derivative nonlinear variable-angle synchronous fluorescence spectrometry.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diflunisal; Fenoprofen; Hydrogen-Ion Concentration; Least-Squares Analysis; Naphthaleneacetic Acids; Nonlinear Dynamics; Reproducibility of Results; Salicylic Acid; Sensitivity and Specificity; Signal Processing, Computer-Assisted; Spectrometry, Fluorescence | 2010 |
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.
Topics: Acetyl Coenzyme A; Acetylation; Animals; Antineoplastic Agents; Binding, Competitive; Catalytic Domain; Cell Line, Tumor; Core Binding Factor Alpha 2 Subunit; Diflunisal; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; HEK293 Cells; Humans; Leukemia, Myeloid, Acute; Leukocytes; Mice; Mice, SCID; Oncogene Proteins, Fusion; p300-CBP Transcription Factors; Protein Binding; RUNX1 Translocation Partner 1 Protein; Salicylic Acid; Signal Transduction; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2016 |
Insight into the release mechanisms of diflunisal and salicylic acid from poly(vinyl alcohol). The role of hydrogen bonding interactions.
Topics: Diflunisal; Hydrogen Bonding; Pharmaceutical Preparations; Polymers; Polyvinyl Alcohol; Protons; Salicylic Acid; Solvents | 2023 |